ICUI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ICUI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, ICU Medical's enterprise value is $3,905 Mil. ICU Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $253 Mil. Therefore, ICU Medical's EV-to-EBITDA for today is 15.42.
The historical rank and industry rank for ICU Medical's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of ICU Medical was 75.06. The lowest was 7.78. And the median was 21.08.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-08), ICU Medical's stock price is $101.66. ICU Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.230. Therefore, ICU Medical's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
The historical data trend for ICU Medical's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
EV-to-EBITDA | Get a 7-Day Free Trial | 18.86 | 22.49 | 21.19 | 27.67 | 15.23 |
ICU Medical Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
EV-to-EBITDA | Get a 7-Day Free Trial | 27.67 | 21.99 | 24.18 | 16.80 | 15.23 |
For the Medical Instruments & Supplies subindustry, ICU Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where ICU Medical's EV-to-EBITDA falls into.
ICU Medical's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 3905.134 | / | 253.201 | |
= | 15.42 |
ICU Medical's current Enterprise Value is $3,905 Mil.
ICU Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $253 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (NAS:ICUI) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
ICU Medical's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 101.66 | / | -1.230 | |
= | At Loss |
ICU Medical's share price for today is $101.66.
ICU Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.230.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of ICU Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniel Woolson | officer: VP, GM-Infusion Capital | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Christian B. Voigtlander | officer: Chief Operating Officer | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Vivek Jain | director, officer: Chairman and CEO | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Elisha W Finney | director | C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304 |
Virginia Ruth Sanzone | officer: VP, General Counsel | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
George A Lopez | director, officer: Chairman, other: Chairman | C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
William Seeger | director | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Smiths Group International Holdings Ltd | 10 percent owner | C/O SMITHS GROUP PLC, 11-12 ST. JAMES'S SQUARE, 4TH FLOOR, LONDON X0 SW1Y 4LB |
Group Plc Smiths | 10 percent owner | 765 FINCHKEY ROAD, LONDON X0 00000 |
Kolleen T Kennedy | director | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Robert S Swinney | director | C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Laurie Hernandez | director | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Brian Michael Bonnell | officer: Chief Financial Officer | ICU MEDICAL INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Scott E Lamb | officer: Controller | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Kevin J Mcgrody | other: Controller | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
From GuruFocus
By GuruFocus Research • 11-07-2023
By GuruFocusNews GuruFocusNews • 12-29-2021
By PRNewswire PRNewswire • 09-03-2021
By Marketwired Marketwired • 09-08-2021
By PRNewswire PRNewswire • 02-02-2021
By GuruFocusNews GuruFocusNews • 03-02-2022
By GuruFocusNews GuruFocusNews • 02-04-2022
By PRNewswire PRNewswire • 02-08-2023
By PurpleRose PurpleRose • 07-19-2022
By Marketwired Marketwired • 02-24-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.